Spain (ES)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies (2021) Espinosa-Ortega F, Holmqvist M, Lodin K, Dastmalchi M, Danieli MG, Venkovsky J, Knitza J, et al. Conference contribution Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations (2021) Rosinol L, Beksac M, Zamagni E, Van De Donk NWCJ, Anderson KC, Badros A, Caers J, et al. Journal article, Review article European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma (2021) Bruno B, Wasch R, Engelhardt M, Gay F, Giaccone L, D'Agostino M, Rodriguez-Lobato LG, et al. Journal article, Review article Carotid Ultrasound Boundary Study (CUBS): An Open Multicenter Analysis of Computerized Intima–Media Thickness Measurement Systems and Their Clinical Impact (2021) Meiburger KM, Zahnd G, Faita F, Loizou CP, Carvalho C, Steinman DA, Gibello L, et al. Journal article Update of the ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (2021) Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, et al. Conference contribution Guideline development GEC ESTRO (2021) Strnad V, Perez-Calatayud J, Jurgenliemk-Schulz I Conference contribution Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability (2021) Dromain C, Sundin A, Najran P, Vidal Trueba H, Dioguardi Burgio M, Crona J, Opalinska M, et al. Journal article How can we estimate QALYs based on PHQ-9 scores? Equipercentile linking analysis of PHQ-9 and EQ-5D (2021) Furukawa TA, Levine SZ, Buntrock C, Ebert DD, Gilbody S, Brabyn S, Kessler D, et al. Journal article Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival (2021) Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. Journal article Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke (2021) Boehm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, et al. Journal article